Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (NCT07852676) titled 'Effect of Bioflor on Gut Microbiota in Proton-Pump Inhibitor Users' on Sept. 25.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Seoul National University Hospital
Condition:
Dysbiosis
Gastroesophageal Reflux Disease (GERD)
Intervention:
Drug: Saccharomyces Boulardii 250 MG
Recruitment Status: Not recruiting
Phase: Phase 4
Date of First Enrollment: July 18, 2024
Target Sample Size: 80
Countries of Recruitment:
South Korea
To know more, visit https://clinicaltrials.gov/study...